Krystal Biotech announced the appointment of Catherine Mazzacco to its Board of Directors. Mazzacco was CEO and President of LEO Pharma, a privately owned global pharmaceutical company
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KRYS:
- Goldman Sachs Sees Over 60% Upside in These 3 Lesser-Known Stocks — Here’s Why They Could Jump
- Krystal Biotech Appoints Catherine Mazzacco to Board of Directors
- Krystal Biotech director Rossi sells 40,000 common shares
- Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs
- Krystal Biotech reports Q4 EPS ($1.25), consensus ($1.32)